From bench to bedside, blade, and back: FAP expression in juvenile angiofibroma. Potential implications for FAPI-PET/CT imaging and targeted therapy?
- PMID: 40694103
- DOI: 10.1007/s00259-025-07468-9
From bench to bedside, blade, and back: FAP expression in juvenile angiofibroma. Potential implications for FAPI-PET/CT imaging and targeted therapy?
Abstract
Purpose: Juvenile angiofibroma (JA) is a rare, benign fibrovascular tumor that predominantly affects adolescent males. The underlying biological mechanisms remain poorly understood. Fibroblast activation protein (FAP), known for its involvement in tumor invasion, matrix remodeling, and angiogenesis, has been implicated in various malignancies but has not been studied in JA so far.
Methods: We investigated FAP expression in JA samples (N = 19) using real-time (RT)-PCR (N = 10) and immunohistochemistry (N = 18). In addition, Vimentin and PECAM1/CD31 were analyzed to further characterize the tumor microenvironment. For one patient, preoperative FAPI-PET/CT imaging was conducted, and FAP expression was correlated with radiotracer uptake. Postoperative histopathological analyses of the excised tumor were performed to validate the imaging findings.
Results: We found consistent expression of FAP, Vimentin and PECAM1/CD31 in all JA analyzed by RT-PCR. Moreover, substantial intra-and intertumor heterogeneity in FAP protein expression was observed, ranging from negative up to strong positive areas. Vimentin and PECAM1/CD31 showed variable expression patterns consistent with the fibrovascular character of JA. FAPI-PET/CT imaging accurately identified the tumor, with radiotracer uptake closely matching the distribution of FAP expression observed histologically.
Conclusions: This study is the first demonstrating FAP expression in JA and validating its occurrence using FAPI-PET/CT imaging. The strong correlation between FAP expression and radiotracer uptake in FAPI-PET/CT highlights the potential of this imaging modality as a non-invasive diagnostic tool. This will improve diagnosis and is the basis for further investigations of FAP-targeted therapies for JA treatment.
Keywords: Epithelial-Mesenchymal Transition (EMT); FAPI-PET/CT; Fibroblast Activation Protein (FAP); Juvenile angiofibroma; Non-invasive imaging; Tumor biomarker.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Ethics approval/institutional review board statement: The study was conducted in accordance with the Declaration of Helsinki and approved by the Institutional Review Board (or Ethics Committee) of Saarland University (protocol code #218/10, approved on 16 December 2010). Consent to participate: Informed Consent Statement: Informed consent was obtained from all subjects involved in the study. Consent to publish: The authors affirm that human research participants provided informed consent to publish all data and images in this article. Conflicts of interest: The authors declare no conflicts of interest.
Similar articles
-
A rationally designed nuclei-targeting FAPI 04-based molecular probe with enhanced tumor uptake for PET/CT and fluorescence imaging.Eur J Nucl Med Mol Imaging. 2024 May;51(6):1593-1604. doi: 10.1007/s00259-024-06691-0. Epub 2024 Mar 21. Eur J Nucl Med Mol Imaging. 2024. PMID: 38512485
-
FAP and PSMA Expression by Immunohistochemistry and PET Imaging in Castration-Resistant Prostate Cancer: A Translational Pilot Study.J Nucl Med. 2024 Dec 3;65(12):1952-1958. doi: 10.2967/jnumed.124.268037. J Nucl Med. 2024. PMID: 39477498 Free PMC article.
-
Discrimination between Inflammatory and Fibrotic Activity in Crohn's Disease-Associated Ileal-Colonic Anastomotic Strictures by Combined Ga-68-FAPI-46 and F-18-FDG-PET/CT Imaging.Visc Med. 2025 Feb;41(1):1-13. doi: 10.1159/000542160. Epub 2024 Dec 20. Visc Med. 2025. PMID: 39927190
-
123I-MIBG scintigraphy and 18F-FDG-PET imaging for diagnosing neuroblastoma.Cochrane Database Syst Rev. 2015 Sep 29;2015(9):CD009263. doi: 10.1002/14651858.CD009263.pub2. Cochrane Database Syst Rev. 2015. PMID: 26417712 Free PMC article.
-
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3. Cochrane Database Syst Rev. 2022. PMID: 35593186 Free PMC article.
References
-
- Schick B, Urbschat S. New aspects of pathogenesis of juvenile angiofibroma. Hosp Med. 2004;65:269–73. - PubMed
-
- Schick B, Dlugaiczyk J, Wendler O. Expression of sex hormone receptors in juvenile angiofibromas and antiproliferative effects of receptor modulators. Head Neck. 2014;36:1596–603. - PubMed
-
- Starlinger V, Wendler O, Gramann M, Schick > Bernhard. Laminin expression in juvenile angiofibroma indicates vessel’s early developmental stage. Acta Oto-Laryngol. 2007;127:1310–5.
LinkOut - more resources
Full Text Sources
Miscellaneous